Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Secondary Headache Disorders in Turkey, the Middle East, Asia, and Africa: A Cross-Sectional, Multicenter Study Publisher Pubmed



Evlice A1 ; Genc H2 ; Uluduz D3 ; Baykan B4 ; Bolay H5 ; Unalcevik I6 ; Kissani N7 ; Luvsannorov O8 ; Togha M9 ; Ozge A10
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, Cukurova University Faculty of Medicine, Adana, Turkey
  2. 2. Department of Neurology, University of Health Sciences, Van Training and Research Hospital, Van, Turkey
  3. 3. Department of Neurology, Istanbul University, Cerrahpasa Faculty of Medicine, Istanbul, Turkey
  4. 4. Istanbul University, Istanbul Faculty of Medicine, EMAR Medical Center, Istanbul, Turkey
  5. 5. Department of Neurology, Gazi University Faculty of Medicine, Ankara, Turkey
  6. 6. Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey
  7. 7. Neuroscience Research Laboratory, Marrakesh Medical School, Cadi Ayyad University, Marrakech, Morocco
  8. 8. Department of Neurology, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  9. 9. Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Department of Neurology, Mersin University Faculty of Medicine, Mersin, Turkey

Source: Cephalalgia Published:2023


Abstract

Background: This multicenter cross-sectional study aimed to determine the frequency and characteristics of secondary headaches in different geographic regions, including Turkey, the Middle East, Asia, and Africa. Methods: Patients were admitted to the study on a particular day each week for five consecutive weeks between 1 April and 16 May 2022. Before the study, all researchers underwent a constructed briefing about the use and code of the ICHD-3 criteria. The study was conducted in two stages. In the first stage, data on secondary headaches were compared between the regions. In the second stage, the sub-diagnoses of secondary headaches were analyzed only in Turkey. Results: A total of 4144 (30.0%) of the 13,794 patients reported headaches as the main symptoms at admission. A total of 422 patients were excluded from the study. In total, 1249 (33.4%) of 3722 patients were diagnosed as having secondary headaches (Turkey [n = 1039], Middle East [n = 80], Asia [n = 51], Africa [n = 79]). The frequency of secondary headaches (Turkey 33.6%, Africa 30.1%, Middle East 35.5%, Asia 35.4%) did not differ significantly between the regions (p > 0.05). The most common subtype of secondary headaches was headache attributed to substances or their withdrawal in all the studied regions. There was a female predominance in all regions, but it was lower in Africa than in Turkey. The severity and density of headaches differed significantly between the regions, with patients from Africa reporting milder pain than patients from other regions. In Turkey, the most common sub-diagnoses of secondary headaches were medication overuse headache, idiopathic intracranial hypertension, and cervicogenic headache. Conclusion: In the present study, one in three patients with a headache had a secondary headache. Headache attributed to substances or their withdrawal was the most common subtype of secondary headaches in all the studied regions. The female predominance of secondary headaches was lower in Africa than in Turkey. The severity and density of headaches differed significantly between regions, with patients from Africa reporting milder pain. © International Headache Society 2023.
Other Related Docs
9. Medication Overuse Headache, Headache and Migraine in Practice (2022)